日本ベクトン・ディッキンソン 品質管理・研究開発・注射剤の製剤研究・CMO Official site

BD BBL Sabouraud Dextrose LP Agar

Effective for 6 months at room temperature! Aerobic culture is possible within 5 days at 22.5°C ± 2.5°C.

Our company handles the "BD BBL Sabouraud Dextrose LP Agar Medium" compliant with the Japanese Pharmacopoeia. It has a shelf life of 6 months when stored at room temperature. Aerobic culture is possible within 5 days at 22.5°C ± 2.5°C. We deliver fresh media from our domestic factory in Japan. 【Composition (per 1L of purified water)】 ■ Casein pancreatic digest: 5.0 g ■ Pepsin digest of animal tissue: 5.0 g ■ Glucose: 40.0 g ■ Agar: 15.0 g ■ Lecithin: 0.7 g ■ Polysorbate: 5.0 g ■ Final pH = 5.6 ± 0.2 *For more details, please refer to the PDF document or feel free to contact us.

basic information

For more details, please refer to the PDF document or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the PDF document or feel free to contact us.

BD BBL(TM) Subrodecxtrose LP Agar

PRODUCT

BD BBL(TM) Subrodecistrose Agar Medium Performance Verification

APPLICATION_NOTE

Recommended products

Distributors

BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.